HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety.

AbstractOBJECTIVE:
To assess efficacy of cervico-vaginal fetal fibronectin as a predictor of spontaneous preterm birth in a high risk antenatal population, and to evaluate the psychological impact of fetal fibronectin testing.
DESIGN:
An observational study.
SETTING:
The antenatal clinic at a tertiary referral hospital.
POPULATION:
One hundred and forty-six pregnant women with known risk factors for spontaneous preterm birth.
METHODS:
Women designated as 'at risk' for preterm delivery by clinical history were screened for fetal fibronectin at 24 and again at 27 weeks of gestation. Anxiety levels were assessed by questionnaire and compared with anxiety levels of 206 low risk women also tested for fetal fibronectin. Fetal fibronectin results were disclosed to the woman and her clinician.
MAIN OUTCOME MEASURES:
Maternal anxiety and efficacy of the 24-week fetal fibronectin test to predict delivery before 30, 34 and 37 weeks of gestation.
RESULTS:
Maternal anxiety was higher pretesting in those at high risk compared with low risk women undergoing the test. Among the high risk women, anxiety was raised to clinically significant levels in those receiving a positive fetal fibronectin screening test result. In all women, 5%, 9% and 21% delivered <30, <34 or <37 weeks of gestation, respectively. Nine percent (n= 13) tested positive for fetal fibronectin at 24 weeks. Predictive power for fetal fibronectin (24 weeks) was greatest for delivery <30 weeks of gestation, with a likelihood ratio of 15 for a positive test (6/13 positive women delivered before 30 weeks).
CONCLUSIONS:
Fetal fibronectin was most efficient as a predictor of preterm spontaneous delivery <30 weeks of gestation, but was associated with high levels of anxiety.
AuthorsAndrew Shennan, Griff Jones, Jennifer Hawken, Sarah Crawshaw, Jeanette Judah, Victoria Senior, Theresa Marteau, Susan Chinn, Lucilla Poston
JournalBJOG : an international journal of obstetrics and gynaecology (BJOG) Vol. 112 Issue 3 Pg. 293-8 (Mar 2005) ISSN: 1470-0328 [Print] England
PMID15713142 (Publication Type: Journal Article, Multicenter Study)
Chemical References
  • Biomarkers
  • FFN protein, human
  • Fibronectins
  • Glycoproteins
Topics
  • Adult
  • Anxiety (etiology)
  • Biomarkers (analysis)
  • Cervix Uteri (chemistry)
  • Female
  • Fibronectins (analysis)
  • Glycoproteins (analysis)
  • Humans
  • Middle Aged
  • Predictive Value of Tests
  • Pregnancy
  • Pregnancy Trimester, Second
  • Pregnancy, High-Risk (psychology)
  • Premature Birth (diagnosis, psychology)
  • Prenatal Diagnosis (methods, psychology, standards)
  • Survival Analysis
  • Vagina (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: